Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Republic of Korea.
Eur J Cardiothorac Surg. 2012 Feb;41(2):383-90. doi: 10.1016/j.ejcts.2011.05.016. Epub 2011 Dec 12.
Calcification plays a major role in the failure of bioprosthetic and other tissue heart valve substitutes. The objective of this study was to evaluate the anticalcification effect of decellularization and detoxification in glutaraldehyde (GA)/genipin- and solvent-fixed bovine pericardium using a rabbit intramuscular model which is effective for assessing calcification in bioprosthetic tissue.
Bovine pericardial tissues were fixed with 0.5% GA/0.4% genipin in organic solvent (75% ethanol + 5% octanol, 75% ethanol + 5% octanediol, or 70% ethanol + 10% isopropanol) and post-treated with glycine, glutamic acid, or sodium bisulfite. Decellularization was performed with 0.25% sodium dodecylsulfate prior to fixation. The material characteristics of the treated tissues were assessed by thermal stability test, uniaxial mechanical test, and light microscopy. Stability of the treated tissue was measured by the resistance to enzymatic degradation using protease. The tissues were intramuscularly implanted into 4-week-old rabbits for 8 weeks, and the anti-α-Gal(Gal[alpha]1,3-Gal[beta]1,4GlcNAc-R) antibodies (immunoglobulin G) were measured at various time intervals after implantation. Explanted tissues were examined by light microscopy and calcium contents of the explanted tissues were measured.
Differently treated tissues resulted in no significant alterations in material characteristics and morphology. GA groups are superior to genipin groups in tissue cross-linking without difference according to addition of decellularization, organic solvent treatment, and detoxification by resistance toward pronase degradation. The titer of anti-α-Gal antibodies gradually increased after implantation in all study groups. The titer of anti-α-Gal antibodies increased less in genipin groups than in GA groups, and less with decellularization than without decellularization. The calcium contents of genipin groups (n = 75) were significantly lower than those of GA groups (n = 118) (28.55 ± 11.22 μg mg(-1) vs 37.16 ± 7.75 μg mg(-1), p < 0.001). Calcium contents decreased with decellularization, organic solvent treatment, and detoxification, irrespective of the type of organic solvent and amino acids. Inorganic phosphorus contents of genipin groups (n = 66) were significantly lower than those of GA groups (n = 103) (55.36 ± 26.98 μg mg(-1) vs 75.67 ± 23.44 μg mg(-1), p = 0.000).
Genipin fixation is a novel alternative to conventional GA fixation in vitro material assessment and in vivo anticalcification effect. The addition of decellularization, organic solvent treatment, and detoxification prevented calcification of GA/genipin-fixed bovine pericardium in the rabbit intramuscular implantation model, irrespective of the type of organic solvent and amino acids.
钙化在生物假体和其他组织心脏瓣膜替代品失效中起着重要作用。本研究的目的是使用兔肌肉内模型评估脱细胞和解毒对戊二醛(GA)/京尼平固定的牛心包的抗钙化作用,该模型对评估生物假体组织中的钙化有效。
用 0.5% GA/0.4%京尼平在有机溶剂(75%乙醇+5%辛醇、75%乙醇+5%辛二醇或 70%乙醇+10%异丙醇)中固定牛心包组织,并用甘氨酸、谷氨酸或亚硫酸氢钠进行后处理。在固定前用 0.25%十二烷基硫酸钠进行脱细胞处理。通过热稳定性试验、单轴力学试验和光镜评估处理组织的材料特性。用蛋白酶测定组织的酶降解抗性来测量处理组织的稳定性。将组织植入 4 周龄的兔子肌肉中 8 周,并在植入后不同时间点测量抗-α-Gal(Gal[alpha]1,3-Gal[beta]1,4GlcNAc-R)抗体(免疫球蛋白 G)。用光镜检查取出的组织,并测量取出组织的钙含量。
不同处理的组织在材料特性和形态上没有明显改变。GA 组在组织交联方面优于京尼平组,而在添加脱细胞、有机溶剂处理和解毒方面没有差异,这可以通过抵抗蛋白酶降解的能力来衡量。所有研究组在植入后抗-α-Gal 抗体的滴度逐渐增加。与 GA 组相比,京尼平组的抗-α-Gal 抗体滴度较低,与无脱细胞处理相比,脱细胞处理的抗-α-Gal 抗体滴度较低。京尼平组(n=75)的钙含量明显低于 GA 组(n=118)(28.55±11.22μgmg(-1)比 37.16±7.75μgmg(-1),p<0.001)。钙含量随脱细胞处理、有机溶剂处理和解毒而降低,与有机溶剂和氨基酸的类型无关。京尼平组(n=66)的无机磷含量明显低于 GA 组(n=103)(55.36±26.98μgmg(-1)比 75.67±23.44μgmg(-1),p=0.000)。
京尼平固定是体外材料评估和体内抗钙化效果替代传统 GA 固定的一种新方法。添加脱细胞处理、有机溶剂处理和解毒可防止兔肌肉内植入模型中 GA/京尼平固定的牛心包钙化,与有机溶剂和氨基酸的类型无关。